510(k) K222591
K222591 is an FDA 510(k) premarket notification submitted by Becton, Dickinson And Company for the device "BD BACTEC Plus Aerobic/F Culture Vials". The FDA issued a decision of Substantially Equivalent on Mar 24, 2023. The device falls under product code MDB (System, Blood Culturing), a Class I device regulated under 21 CFR 866.2560. Becton, Dickinson And Company has 330 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Mar 24, 2023
- Date Received
- Aug 26, 2022
- Clearance Type
- Special
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- System, Blood Culturing
- Device Class
- Class I
- Regulation Number
- 866.2560
- Review Panel
- MI
- Submission Type
- 510(k)
Need the full FDA record for Becton, Dickinson And Company? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.